Your browser doesn't support javascript.
loading
Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic
Almeida, Madson Q; Mendonca, Berenice B.
  • Almeida, Madson Q; Universidade de Sao Paulo. Hospital das Clinicas HCFMUSP. Sao Paulo. BR
  • Mendonca, Berenice B; Universidade de Sao Paulo. Hospital das Clinicas. Sao Paulo. BR
Clinics ; 75: e2022, 2020. tab
Article in English | LILACS | ID: biblio-1133398
ABSTRACT
The coronavirus disease 2019 (COVID-19) is an emerging pandemic challenge. Acute respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine storm. Patients undergoing glucocorticoid (GC) replacement therapy for adrenal insufficiency (AI) represent a highly vulnerable group that could develop severe complications due to the SARS-CoV-2 infection. In this review, we highlight the strategies to avoid an adrenal crisis in patients with AI and COVID-19. Adrenal crisis is a medical emergency and an important cause of death. Once patients with AI present symptoms of COVID-19, the dose of GC replacement therapy should be immediately doubled. In the presence of any emergency warning signs or inability to administer oral GC doses, we recommend that patients should immediately seek Emergency services to evaluate COVID-19 symptoms and receive 100 mg hydrocortisone by intravenous injection, followed by 50 mg hydrocortisone intravenously every 6 h or 200 mg/day by continuous intravenous infusion.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Hydrocortisone / Adrenal Insufficiency / Coronavirus Infections / Betacoronavirus / Glucocorticoids Type of study: Etiology study Limits: Humans Language: English Journal: Clinics Journal subject: Medicine Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de Sao Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Hydrocortisone / Adrenal Insufficiency / Coronavirus Infections / Betacoronavirus / Glucocorticoids Type of study: Etiology study Limits: Humans Language: English Journal: Clinics Journal subject: Medicine Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade de Sao Paulo/BR